• Tatjana Cepreganova Cangovska Faculty of Medicine, Goce Delcev University in Stip, North Macedonia
  • Ilija Zdravkov General City Hospital, 8th September ,Skopje, North Macedonia
  • Angela Aleksovska General City Hospital, 8th September ,Skopje, North Macedonia
  • Daniela Ristic-Stomnaroska General City Hospital, 8th September , Skopje, Faculty of Medicine, Goce Delcev University in Stip, North Macedonia
  • Elena Joveva Clinical Public Hospital, Stip, North Macedonia


Mycobacterium tuberculosis is the leading cause of morbidity and mortality worldwide. Tuberculosis is the second most common cause of death due to an infectious agent worldwide after COVID-19 infection. Central nervous system tuberculosis (CNS-TB), accounts for approximately 1% of all cases of tuberculosis, and the most common clinical presentation is tuberculous meningitis (TBM). Tuberculosis of the central nervous system is a devastating disease that, even under appropriate antituberculin therapy, leads to high mortality rate. In this paper we present a case report of a patient in whom the disease begins slowly, progressively and chronically, with the initial clinical manifestation of dementia syndrome. Usually, TBM presents with a subacute progressive febrile illness. In 2 to 3 weeks defines meningitis phase with headache, meningismus, vomiting, mild confusion. Rare is the atypical presentation of CNS TB, as in our case. During the hospitalization, brain magnetic resonance was performed with suspicious finding for neuroinfection, Due to the suspected finding of magnetic resonance imaging, a lumbar puncture was performed and the cerebrospinal fluid was sent for analysis for specific causes, including Mycobacterium tuberculosis. Correct diagnosis and therapy in these patients are a challenge for neurologists.

Key words: central nervous system tuberculosis, mycobacterium tuberculosis, neuroinfection.



1.Centers for Disease Control and Prevention. 2010. Data and statistics. Centers for Disease Control and P revention, Atlanta, GA. http://www.cdc.gov/tb/surv/statistics/default.htm.
2. Davis AG, Rohlwink UK, Proust A, Figaji AA, Wilkinson RJ. The pathogenesis of tuberculous meningitis. J Leukoc Biol. 2019;105(2):267-80.
3. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA. 1979;241(3):264-8.
4. Hinman AR. Tuberculous meningitis at Cleveland Metropolitan General Hospital 1959 to 1963. Am Rev Respir Dis. 1967;95(4):670-3.
5. Farinha NJ, Razali KA, Holzel H, Morgan G, Novelli VM. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect. 2000;41(1):61-8.
6. Udani PM, Dastur DK. Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations. J Neurol Sci. 1970;10(6):541-61.
7. Bernaerts A, Vanhoenacker FM, Parizel PM, Van Goethem JW, Van Altena R, Laridon A, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol. 2003;13(8):1876-90.
8.Ozateş M, Kemaloglu S, Gürkan F, Ozkan U, Hoşoglu S, Simşek MM. CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol. 2000;41(1):13-7.
9. American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1-77.
10. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):e147-e195.
How to Cite
CEPREGANOVA CANGOVSKA, Tatjana et al. CENTRAL NERVOUS SYSTEM TUBERCULOSIS- CASE REPORT CASE REPORT. Journal of Morphological Sciences, [S.l.], v. 6, n. 2, p. 104-108, nov. 2023. ISSN 2545-4706. Available at: <https://jms.mk/jms/article/view/vol6no2-14>. Date accessed: 23 apr. 2024.